Clinical Trial Update: Scheduling Nab-paclitaxel With Gemcitabine [Phase 2]

View source ↗

Summary

Phase 2 trial update on scheduling nab-paclitaxel with gemcitabine in metastatic pancreatic adenocarcinoma завершено.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma Metastatic

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: CCTU- Cancer Theme | Conditions: Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: COMPLETED